chartexchange

AstraZeneca Made $10 Billion Offer for Rhythm Pharmaceuticals

The Wall Street Journal | Nov 4, 2026 3:57 PM EST

Rhythm specializes in treatments for metabolic conditions and severe obesity.

Read original article